TABLE 3.
Multivariable linear regression models for change in kidney function by various methods of measurement (n = 20). The ReShape CV‐Risk Study
| Dependent variable | ||||||||
|---|---|---|---|---|---|---|---|---|
| Change in measured GFR | Change in estimated GFRcrea | Change in estimated GFRcys | Change in estimated GFRcreacys | |||||
| Independent variables in the multivariable model | Standardized regression coefficient | P value | Standardized regression coefficient | P value | Standardized regression coefficient | P value | Standardized regression coefficient | P value |
| Baseline age, per year | −0.57 | .029 | 0.25 | .28 | −0.03 | .89 | 0.17 | .50 |
| Change in ambulatory systolic BP, per mm Hg | 0.26 | .30 | 0.61 | .011 | 0.40 | .11 | 0.50 | .051 |
| Baseline GFR (same method), per ml/min/1.73 m2 | −0.32 | .26 | 0.09 | .73 | −0.64 | .026 | −0.30 | .29 |
| Baseline urinary albumin‐creatinine ratio, per mg/mmol | −0.22 | .42 | −0.21 | .40 | −0.48 | .055 | −0.50 | .060 |
| Baseline urinary NAG‐creatinine ratio, per U/g | −0.36 | .14 | −0.21 | .37 | −0.26 | .34 | −0.27 | .33 |
Abbreviations: BP, Blood pressure; GFR, Glomerular filtration rate; NAG, N‐acetyl‐β‐D‐glucosaminidase.
Estimated GFRcrea, GFRcys,and GFRcreacys refer to GFR estimates calculated with the CKD‐EPI equations based on creatinine, cystatin C and creatinine + cystatin C, respectively.